The first few weeks of September have brought more chapters in the story of Congress’s consideration of how to fix problems with aspects of the American health care system including what, if anything, should come after the Affordable Care Act (ACA).
Prescription drugs are often singled out for blame on the rising cost of health care. Do the critics have their facts right? And if so, what can employers and policymakers do about it?
Seven years after the passage of the Affordable Care Act (ACA), the political barriers to a substantive national dialogue to advance sound health care policy are once again front and center.
Can you share your health innovation success story to give federal lawmakers a better understanding of health benefits issues?
What will happen to employer-sponsored health benefits if the American Health Care Act (AHCA) becomes law? At the March 2017 Alliance Learning Circle attorney John Barlament, partner at Quarles & Brady, weighed in on the murky scenarios created by the AHCA bill introduced by Republicans in the U.S. House of Representatives.
Health Policy in Transit offers “common sense” recommendations from employers like us to U.S. lawmakers considering changes to the Affordable Care Act.